SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-051664
Filing Date
2018-10-01
Accepted
2018-10-01 07:05:48
Documents
27
Period of Report
2018-10-01

Document Format Files

Seq Description Document Type Size
1 6-K tv503873_6k.htm 6-K 9871
2 EXHIBIT 99.1 tv503873_ex99-1.htm EX-99.1 30367
3 GRAPHIC image_001.jpg GRAPHIC 65139
4 GRAPHIC image_002.jpg GRAPHIC 564400
5 GRAPHIC image_003.jpg GRAPHIC 280162
6 GRAPHIC image_004.jpg GRAPHIC 199013
7 GRAPHIC image_005.jpg GRAPHIC 276944
8 GRAPHIC image_006.jpg GRAPHIC 242399
9 GRAPHIC image_007.jpg GRAPHIC 262990
10 GRAPHIC image_008.jpg GRAPHIC 27748
11 GRAPHIC image_009.jpg GRAPHIC 262650
12 GRAPHIC image_010.jpg GRAPHIC 280086
13 GRAPHIC image_011.jpg GRAPHIC 196639
14 GRAPHIC image_012.jpg GRAPHIC 240263
15 GRAPHIC image_013.jpg GRAPHIC 305251
16 GRAPHIC image_014.jpg GRAPHIC 32735
17 GRAPHIC image_015.jpg GRAPHIC 166720
18 GRAPHIC image_016.jpg GRAPHIC 296065
19 GRAPHIC image_017.jpg GRAPHIC 262590
20 GRAPHIC image_018.jpg GRAPHIC 252422
21 GRAPHIC image_019.jpg GRAPHIC 264466
22 GRAPHIC image_020.jpg GRAPHIC 243196
23 GRAPHIC image_021.jpg GRAPHIC 219523
24 GRAPHIC image_022.jpg GRAPHIC 294790
25 GRAPHIC image_023.jpg GRAPHIC 261419
26 GRAPHIC image_024.jpg GRAPHIC 162671
27 GRAPHIC image_025.jpg GRAPHIC 65139
  Complete submission text file 0001144204-18-051664.txt   7929586
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 181095861
SIC: 2834 Pharmaceutical Preparations